albumin binding raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-01-04 and is reviewed periodically as new material appears.
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
| Property | Value | Notes |
|---|---|---|
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
| Common synonyms | GIP/GLP-1 dual agonist; LY3298176 | Development codes appear in earlier literature |
| Purity specification | Usually 95% or higher by HPLC area | Research-grade lots are often 98% or higher |
| Solution storage | 2–8 °C, protected from light | Short term; avoid repeated freeze-thaw cycles |
| Dry powder storage | −20 °C or below, desiccated | Protected from moisture and light |
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
=== Seed === Plant cryopreservation is becoming vital for its biodiversity value. Seeds are often considered as an important delivery system of genetic information. Cryopreservation of recalcitrant seed is the hardest due to intolerance to low temperature and low water content. However, plant vitrification solution can solve the problem and help recalcitrant seed (Nymphaea caerulea) cryopreserve.
== Ban == The BBB was banned, and restrictions were placed on the political activities of Schabort in November 1988, in reaction to the massacre of black South Africans in Pretoria by Barend Strydom. This was the first time such restrictions had been placed on a right wing organisation. In banning the group, Adriaan Vlok, the Law and Order Minister, said that the group were "right-wing, fanatical extremists who favour violence to carry racism to its extreme". In December 1988, Schabort re-launched the BBB as the Blanke Nasionale Beweging (White National Movement) under the nominal leadership of Wynand de Beer; however, as its activities were clearly the same as the BBB, it was banned at the beginning of 1989. The government lifted the ban on the BBB in February 1990. Schabort officially disbanded the BBB and the Blanke Party in 1990, and joined the Conservative Party. Some members of the BBB, like Keith Conroy, would go on to support the Afrikaner Volksfront.
== Environmental factors == Living in an environment with more green spaces is associated with higher well-being, partly due to the beneficial effects on psychological relaxation, stress alleviation, increased physical activity, and reduced exposure to air pollutants and noise, among others. According to the latest systematic review of the economic literature on life satisfaction, pollution is bad for one's well-being. Exposure to outdoor air pollution and chimney smoke fireplaces causes dementia and other-health risks. Climate change mitigation measures have mostly positive direct effects on human well-being.
Viola species can be annual or perennial, and can take the form of herbs, shrubs or very rarely treelets. In acaulescent taxa the foliage and flowers appear to rise from the ground. The remainder have short stems with foliage and flowers produced in the axils of the leaves (axillary). They typically have heart-shaped or reniform (kidney-shaped) scalloped leaves, though a number have linear or palmate leaves. The simple leaves of plants with either habit are arranged alternately; the acaulescent species produce basal rosettes. Plants always have leaves with stipules that are often leaf-like. The flowers of the vast majority of the species are strongly zygomorphic with bilateral symmetry and solitary, but occasionally form cymes. The flowers are formed from five petals; four are upswept or fan-shaped with two per side, and there is one, broad, lobed lower petal pointing downward. This petal may be slightly or much shorter than the others and is weakly differentiated. The shape of the petals and placement defines many species, for example, some species have a "spur" on the end of each petal while most have a spur on the lower petal. The spur may vary from scarcely exserted (projecting) to very long, such as in Viola rostrata. Solitary flowers end long stalks with a pair of bracteoles. The flowers have five sepals that persist after blooming, and in some species the sepals enlarge after blooming. The corolla ranges from white to yellow, orange or various shades of blue and violet or multicolored, often blue and yellow, with or without a yellow throat.
Sources: en.wikipedia.org
The Matrix Revolutions begins immediately after the events of the second movie; as a result of his struggle with the sentinels, Neo returns to consciousness finding himself caught in an isolated train station-like limbo only accessible by order of the Merovingian, from which his mind is unable to free itself. It is here that he meets Sati, a young program created without a purpose, who is being smuggled into the Matrix by her parents, also programs in the machine world. Neo remains trapped until he is freed by Trinity (assisted by Morpheus and Seraph), who threatens the Merovingian in a Mexican standoff. After a final visit to the Oracle, Neo learns that he has powers over the machines which extend beyond the Matrix and that Smith is spreading, threatening to destroy both the Matrix and the real world. Building on the Oracle's previous explanations about the nature of choice, Neo learns that the Architect's assertion that his choice to save Trinity would inherently lead to the extinction of humankind was incorrect, due to his nature as a purely mathematical being rendering him incapable of seeing past choices made by humans, as he considers them mere variables in equations. Having told Neo that he now has the power to choose to end the war and defeat Smith, the Oracle then states "everything that has a beginning has an end, Neo" and informs him that in order for true peace to happen, he must travel to the heavily guarded Machine City in the real world and make a truce with the machines in order to save both races from extinction because of Smith's activities.
== Operations == EFLM has an Executive Board and a range of committees for: science, education and training, quality and regulations, communication and professional representation. Each committee has working groups with a Chair and three full members, there is also a Young Scientist member and they may also have corresponding members, but only one member form each country is permitted. The Science Committee develops collaborative science in Laboratory Medicine between member organisations or individuals and guidelines to set standards of practice to assist member societies in providing quality patient care. The output of the scientific working groups is scientific papers and presentations which contribute to the science of laboratory medicine internationally; a list of publications can be found on the EFLM web-site (link below). Typically publications are peer-reviewed and published in the journal Clinical Chemistry and Laboratory Medicine. The Working Groups are overseen by the Chair of the Science Committee and their activities reviewed annually; scientific and clinically relevant output determine whether they continue. The Education and Training Committee runs educational activities particularly for trainees and those required to develop new skills as well as running scientific and clinical conferences, webinars, etc. The major Congress is Euromedlab held in conjunction with the IFCC, meetings are selected from bids by member societies at the annual General Meeting.
=== Phase 3 === Fasedienol (Aloradine; AM-005; PH-94B; 4-androstadienol) – vomeropherine Soclenicant (BNC-210; IW-2143) – α7 nicotinic acetylcholine receptor negative allosteric modulator (abandoned after failed phase 3 trials. See [1].) VQW-765 (VQW765; AQW051; AQW-051; JQH481R778) – α7 nicotinic acetylcholine receptor partial agonist [2]
=== Mechanism of action === In the setting of HLH, over-secretion of IFN-γ is thought to contribute to the pathogenesis of the disease. Emapalumab binds and neutralizes IFN-γ, preventing it from inducing pathological effects.
The JWP considered that the JINR–LLNL collaborations of 2004 and 2007, producing element 113 as the daughter of element 115, did not meet the discovery criteria as they had not convincingly determined the atomic numbers of their nuclides through cross-bombardments, which were considered necessary since their decay chains were not anchored to previously known nuclides. They also considered that the previous JWP's concerns over their chemical identification of the dubnium daughter had not been adequately addressed. The JWP recognised the JINR–LLNL–ORNL–Vanderbilt collaboration of 2010 as having discovered elements 117 and 115, and accepted that element 113 had been produced as their daughter, but did not give this work shared credit. After the publication of the JWP reports, Sergey Dimitriev, the lab director of the Flerov lab at the JINR where the discoveries were made, remarked that he was happy with IUPAC's decision, mentioning the time Riken spent on their experiment and their good relations with Morita, who had learnt the basics of synthesising superheavy elements at the JINR. The sum argument advanced by the JWP in the approval of the discovery of element 113 was later criticised in a May 2016 study from Lund University and the GSI, as it is only valid if no gamma decay or internal conversion takes place along the decay chain, which is not likely for odd nuclei, and the uncertainty of the alpha decay energies measured in the 278113 decay chain was not small enough to rule out this possibility.
Sources: en.wikipedia.org
Reversed-phase liquid chromatography with ultraviolet detection is the usual approach, frequently combined with mass spectrometry for identity. Purity is reported as the area percentage of the main peak. Related impurities eluting near the main peak are usually summed and reported separately.
Removing water slows hydrolysis and limits aggregation, so dry powder retains its quality attributes longer than a solution. Suppliers define a shelf life and retest date for the dried form at specified temperatures. Once dissolved, the practical working lifetime shortens considerably.
It generally lists appearance, identity by mass, purity by chromatography, water or residual solvent content, and the methods used. Storage recommendations and a retest date are commonly included. Values are reported against a supplier specification rather than a single universal standard.
It is a synthetic 39-amino-acid peptide that acts on two incretin receptors, the GIP receptor and the GLP-1 receptor. It is given by subcutaneous injection and has a circulating half-life of roughly five days. It is not a small molecule and is not absorbed usefully from the gut in conventional oral form.